Journal of the American College of Radiology : JACR · 2026
A Multilevel Intervention to Improve Lung Cancer Screening Among Hispanic Patients: A Pilot Randomized Controlled Trial.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bharucha Mahnur, Gutierrez Omar, Madan Aarushi, Echeverria Richard, Aguilar-Lopez Leonardo, Chen Wen-Pin, Hoyt Michael A, Llave Karen, Lee Sunmin, Nguyen Tan, Ziogas Argyrios, Sadigh Gelareh
Аннотация
PURPOSE: We evaluated the preliminary efficacy of Empower LCS, a culturally-adapted multilevel intervention, compared with enhanced usual care (EUC) for improving LCS uptake among Hispanic patients.
METHODS: In this pilot randomized controlled trial, Hispanic patients aged 50-80 years who met 2021 US Preventive Services Task Force LCS eligibility criteria were enrolled between February 2024 and August 2025. Participants were randomized 1:1 to EUC or Empower LCS. EUC included usual care plus a one-page educational handout. Empower LCS included a culturally adapted decision aid, provider notifications, patient text reminders, and health-related social needs support. The primary outcome was LDCT ordering within 4 months, assessed by medical record review or self-report. Analyses used chi-square tests and logistic regressions.
RESULTS: Sixty patients were randomized (mean age, 60.8 years ± 7.4; 37/60 [61.7%] male; 21/60 [35.0%] Spanish-speaking). At 4 months, LDCT ordering was higher with Empower LCS than with EUC (15/30 [50.0%] vs 4/30 [13.3%]; p=0.002), as were LCS discussions (12/30 [40.0%] vs 5/30 [16.7%]; p=0.045). LDCT completion was higher but not significant (9/30 [30.0%] vs 4/30 [13.3%]; p=0.117), likely due to small sample size. In exploratory adjusted models, Empower LCS was associated with higher odds of LCS ordering (OR, 7.32; 95% CI, 1.97-34.16), and discussion (OR, 4.1; 95% CI, 1.20-16.28). Qualitative interviews identified provider trust and logistical barriers as drivers of screening engagement and completion, respectively.
CONCLUSIONS: Empower LCS increased LDCT ordering and screening discussions in this pilot trial. These findings support culturally tailored, low-cost, scalable interventions to reduce disparities in LCS participation.
METHODS: In this pilot randomized controlled trial, Hispanic patients aged 50-80 years who met 2021 US Preventive Services Task Force LCS eligibility criteria were enrolled between February 2024 and August 2025. Participants were randomized 1:1 to EUC or Empower LCS. EUC included usual care plus a one-page educational handout. Empower LCS included a culturally adapted decision aid, provider notifications, patient text reminders, and health-related social needs support. The primary outcome was LDCT ordering within 4 months, assessed by medical record review or self-report. Analyses used chi-square tests and logistic regressions.
RESULTS: Sixty patients were randomized (mean age, 60.8 years ± 7.4; 37/60 [61.7%] male; 21/60 [35.0%] Spanish-speaking). At 4 months, LDCT ordering was higher with Empower LCS than with EUC (15/30 [50.0%] vs 4/30 [13.3%]; p=0.002), as were LCS discussions (12/30 [40.0%] vs 5/30 [16.7%]; p=0.045). LDCT completion was higher but not significant (9/30 [30.0%] vs 4/30 [13.3%]; p=0.117), likely due to small sample size. In exploratory adjusted models, Empower LCS was associated with higher odds of LCS ordering (OR, 7.32; 95% CI, 1.97-34.16), and discussion (OR, 4.1; 95% CI, 1.20-16.28). Qualitative interviews identified provider trust and logistical barriers as drivers of screening engagement and completion, respectively.
CONCLUSIONS: Empower LCS increased LDCT ordering and screening discussions in this pilot trial. These findings support culturally tailored, low-cost, scalable interventions to reduce disparities in LCS participation.